IQVIA Israel News and Activities

IQVIA Israel is owned by IQVIA.

IQVIA is one of the...

• Forbes Global 2000 (#680);
• Fortune 500 (#275);
• Global Fortune 500 (#282);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

IQVIA is a company listed under the stock ticker IQV (US).

IQVIA has a direct presence in 22 countries.

IQVIA has 27 subsidiaries including EasyApotheke, IQVIA ANZ and IQVIA APAC.

They are in:

• Healthcare89%
• Pharmaceuticals7%
• Other4%

View the org chart displaying its 2 main executives

Most searched biographies at IQVIA Israel

• Navit BarYehuda, Country Manager and Director R&D
• Selin Zalma, Director, Sales & Account management

Create your alert
to follow the executive moves at IQVIA Israel.

IQVIA has 2,236 competitors including Optum (United States (USA)), UnitedHealth Group (United States (USA)) and Ramsay Santé (France).

Popular M&A news in Healthcare

• Genesis HealthCare has filed for bankruptcy protection Genesis HealthCare  (posted on July 10 2025).
• Abridge has just announced a $300 Million fundraising (posted on June 25 2025).
• Capital Rx has acquired Amino (posted on June 20 2025).

Popular contacts in Healthcare

• Gregory Rice - Chief Scientific Officer at Inoviq
• Ashley Foster - Executive Vice President Acute Partnerships at ShiftMed
• Danielle Jenkins - National Clinical Senior Nurse Director at Medix Infusion

Learn more about the Healthcare industry

Press releases by IQVIA Israel

Social media about IQVIA Israel

• IQVIA Israel on Wikipedia, Google News & Yahoo Finance
• IQVIA Israel on LinkedIn, Twitter & YouTube